Immune barriers are the regulators of the immune system. These pathways are essential for tolerance processes and prevent autoimmune diseases, ie, those pathways that prevent the immune system from acting against the body itself. In cancer, these pathways are activated and as a result, the immune system does not attack the cancer. This way of cancer thrive in the body PD-L1 and CTLA-4 are types of training barriers. This therapeutic strategy has revolutionized the treatment of cancer in recent years and is one of the most studied strategies in the world for many types of cancer and different stages of treatment.
Home » Immunosuppressive barrier
Facebook
Twitter
LinkedIn
WhatsApp
Immunosuppressive barrier
To check if our service suits your case
We need to talk
Improve therapeutic outcomes, prolong life and quality of life, are our main business.
We support access to and expand cancer treatments beyond the standard of care, with the most advanced and innovative treatment options in the world, personally matching the individual cancer patient’s medical condition and with the support of top tier oncologists.
Article categories
קטגוריות המאמרים
Popular topics
Tags
Advanced Cancer Treatment
Alpelisib
ASCO 2025
ASCO 2026
ASCO Breast Cancer
Biological Drugs
Bispecific Antibody
Breast Cancer
Breast Cancer Clinical Trials
Cancer Drug Development
Cancer Research
CAR T treatments
Chemotherapy
Clinical Trials
Genetic Engineering Treatments
Genomic Testing
Head and Neck Cancer
HER3-DXd
HPV-negative HNSCC
HR Positive Breast Cancer
Immunotherapy
Innovative Cancer Treatments
innowacyjne terapie onkologiczne
Keytruda
Medical Cannabis
Metastatic Breast Cancer
Metastatic Head and Neck Cancer
MTAP Deletion
MTAP Loss
nowotwór piersi
Oncology
Palbociclib
PI3K Pathway
PIK3CA Mutation
Precision Oncology
PRMT5 Inhibitor
rak płuca
RAS Mutation
Stage 4 Cancer
Targeted Drugs
Targeted Therapy
terapia ADC
Trial-In Pharma
TUXEDO-3
Vopimetostat






